Metabolism of [14C] papaverine in man. 1982

G Wilén, and P Ylitalo

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010208 Papaverine An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels. Cerespan,Papaverine Hydrochloride,Pavabid,Pavatym,Hydrochloride, Papaverine
D005260 Female Females
D005965 Glucuronates Derivatives of GLUCURONIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the 6-carboxy glucose structure. Glucosiduronates,Glucuronic Acids,Acids, Glucuronic
D005966 Glucuronidase Endo-beta-D-Glucuronidase,Endoglucuronidase,Exo-beta-D-Glucuronidase,beta-Glucuronidase,Endo beta D Glucuronidase,Exo beta D Glucuronidase,beta Glucuronidase
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001192 Arylsulfatases Enzymes that catalyze the hydrolysis of a phenol sulfate to yield a phenol and sulfate. Arylsulfatase A, B, and C have been separated. A deficiency of arylsulfatases is one of the causes of metachromatic leukodystrophy (LEUKODYSTROPHY, METACHROMATIC). EC 3.1.6.1. Arylsulfatase,Arylsulfate Sulfohydrolase,Arylsulfate Sulfohydrolases,Arylsulphatase,Arylsulphatases,Pseudo Arylsulfatase A,Sulfohydrolase, Arylsulfate

Related Publications

G Wilén, and P Ylitalo
September 1953, Journal of applied physiology,
G Wilén, and P Ylitalo
May 1978, Xenobiotica; the fate of foreign compounds in biological systems,
G Wilén, and P Ylitalo
December 1968, The Journal of endocrinology,
G Wilén, and P Ylitalo
May 1982, Xenobiotica; the fate of foreign compounds in biological systems,
G Wilén, and P Ylitalo
October 1968, The Journal of endocrinology,
G Wilén, and P Ylitalo
October 1977, Biomedical mass spectrometry,
G Wilén, and P Ylitalo
June 1977, British journal of anaesthesia,
G Wilén, and P Ylitalo
August 1986, Xenobiotica; the fate of foreign compounds in biological systems,
G Wilén, and P Ylitalo
March 1979, British journal of clinical pharmacology,
Copied contents to your clipboard!